Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 10  •  10:44AM ET
13.52
Dollar change
+0.46
Percentage change
3.51
%
IndexRUT P/E- EPS (ttm)-3.04 Insider Own2.05% Shs Outstand39.52M Perf Week3.75%
Market Cap535.32M Forward P/E- EPS next Y-1.60 Insider Trans-3.13% Shs Float38.79M Perf Month-14.33%
Enterprise Value673.85M PEG- EPS next Q-0.19 Inst Own90.00% Short Float2.75% Perf Quarter-9.64%
Income-119.12M P/S0.65 EPS this Y31.52% Inst Trans-0.76% Short Ratio5.04 Perf Half Y4.47%
Sales818.06M P/B1.21 EPS next Y28.98% ROA-14.01% Short Interest1.07M Perf YTD-10.83%
Book/sh11.20 P/C8.12 EPS next 5Y34.67% ROE-24.60% 52W High20.48 -33.99% Perf Year-25.72%
Cash/sh1.67 P/FCF- EPS past 3/5Y-19.24% -17.02% ROIC-18.53% 52W Low10.24 32.01% Perf 3Y-40.00%
Dividend Est.- EV/EBITDA- Sales past 3/5Y19.84% 11.69% Gross Margin64.64% Volatility3.96% 3.69% Perf 5Y-67.03%
Dividend TTM- EV/Sales0.82 EPS Y/Y TTM3.26% Oper. Margin-11.55% ATR (14)0.51 Perf 10Y-65.14%
Dividend Ex-Date- Quick Ratio1.38 Sales Y/Y TTM4.31% Profit Margin-14.56% RSI (14)45.42 Recom1.80
Dividend Gr. 3/5Y- - Current Ratio2.47 EPS Q/Q19.45% SMA200.24% Beta0.76 Target Price19.50
Payout- Debt/Eq0.46 Sales Q/Q4.59% SMA50-8.26% Rel Volume0.79 Prev Close13.06
Employees1616 LT Debt/Eq0.45 EarningsFeb 24 BMO SMA200-0.77% Avg Volume211.45K Price13.52
IPOApr 24, 1992 Option/ShortYes / Yes EPS/Sales Surpr.-2.21% 2.21% Trades Volume38,221 Change3.51%
Date Action Analyst Rating Change Price Target Change
Jan-27-26Initiated TD Cowen Hold $14
Oct-28-25Resumed Stifel Buy $22
Jan-22-25Initiated Canaccord Genuity Buy $24
Nov-08-24Upgrade Stifel Hold → Buy $18 → $24
May-08-24Upgrade ROTH MKM Neutral → Buy $15 → $20
Oct-20-23Initiated ROTH MKM Neutral $12
Sep-12-23Downgrade Stifel Buy → Hold
Sep-12-23Downgrade BTIG Research Buy → Neutral
Jul-19-23Resumed BTIG Research Buy $27
Mar-04-22Upgrade Stifel Hold → Buy $41 → $45
Today 07:00AM
Feb-03-26 07:00AM
Jan-09-26 07:00AM
Nov-04-25 04:08PM
08:20AM
07:19AM Loading…
07:19AM
07:00AM
Nov-03-25 07:56AM
Oct-31-25 05:42PM
Oct-15-25 07:00AM
Oct-14-25 07:00AM
Oct-07-25 11:40AM
Oct-03-25 06:49PM
Oct-02-25 10:13AM
Sep-15-25 09:12AM
12:08PM Loading…
Aug-13-25 12:08PM
Aug-07-25 11:40AM
Aug-05-25 08:25AM
07:25AM
07:00AM
Aug-04-25 10:00AM
07:40AM
Jul-16-25 07:00AM
Jul-15-25 07:00AM
Jun-17-25 07:00AM
May-07-25 03:09AM
12:09AM
May-06-25 08:35AM
07:36AM
07:00AM
10:08AM Loading…
May-05-25 10:08AM
Apr-22-25 05:15PM
Apr-18-25 02:06PM
Apr-15-25 08:00AM
Mar-19-25 08:00AM
Mar-12-25 08:00AM
Mar-07-25 07:51AM
Mar-03-25 07:00AM
Feb-26-25 02:18AM
02:07AM
Feb-25-25 08:35AM
07:41AM
07:00AM
01:44AM
Feb-17-25 07:05AM
Jan-28-25 07:00AM
Nov-12-24 07:05AM
Nov-08-24 07:32AM
02:14AM
Nov-07-24 08:25AM
07:23AM
07:05AM
07:05AM
Nov-06-24 07:30AM
Oct-21-24 07:00AM
Oct-10-24 07:00AM
Oct-09-24 12:34PM
Sep-27-24 05:45AM
Sep-23-24 07:00AM
Sep-13-24 05:45AM
Aug-30-24 10:22AM
Aug-15-24 05:52PM
Aug-07-24 06:09AM
Aug-06-24 08:15AM
07:17AM
07:03AM
Jul-17-24 07:00AM
Jul-16-24 07:00AM
Jul-10-24 12:13PM
06:32AM
Jul-09-24 07:00AM
07:00AM
Jun-24-24 07:00AM
03:11AM
Jun-18-24 07:00AM
Jun-11-24 07:00AM
May-23-24 07:00AM
May-16-24 07:15AM
May-13-24 11:18AM
May-09-24 07:00AM
May-08-24 01:03PM
07:43AM
03:16AM
May-07-24 10:38PM
01:53PM
09:34AM
08:21AM
08:00AM
Apr-26-24 06:37AM
Apr-23-24 07:00AM
Apr-16-24 07:00AM
Mar-18-24 07:00AM
Mar-12-24 11:01AM
Mar-07-24 01:40PM
09:53AM
Mar-06-24 08:21AM
Mar-05-24 10:52PM
04:42PM
04:03PM
Feb-29-24 07:00AM
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andrews JulieCFOJan 16 '26Sale14.384,87370,07458,039Jan 21 04:09 PM
Calafiore MassimoPresident & CEOJan 09 '26Sale15.829,600151,906227,034Jan 13 05:46 PM
Calafiore MassimoPresident & CEOJan 12 '26Sale15.219,797149,050217,237Jan 13 05:46 PM
Fisher PatrickPresident, Global OrthopedicsAug 18 '25Sale14.211,99628,36330,116Aug 20 04:08 PM
Engine Capital Management, LP10% OwnerJul 02 '25Buy11.111,25013,8813,546,057Jul 07 05:43 PM
McPherron AvivaPres, Global Ops & QualJun 18 '25Sale10.513,72839,18146,322Jun 23 04:15 PM
REINHARDT MAXPresident, Global SpineJun 11 '25Sale11.641,64319,12527,481Jun 13 04:10 PM
Bazaar Alan LeeDirectorJun 04 '25Buy10.922,25024,57030,983Jun 05 05:11 PM
Calafiore MassimoPresident & CEOMay 09 '25Buy12.5410,000125,400234,603May 12 07:14 PM
Bazaar Alan LeeDirectorMay 12 '25Buy12.592,00025,17228,733May 12 04:17 PM
Bazaar Alan LeeDirectorMay 09 '25Buy12.621,99025,12026,733May 12 04:17 PM
Engine Capital Management, LP10% OwnerMay 07 '25Buy12.31100,0001,231,0003,544,807May 08 06:38 PM
Cedron Jorge AndresCLOApr 16 '25Sale13.313,81650,79142,500Apr 18 04:18 PM
Gillespie Geoffrey CCAOApr 02 '25Sale15.74761,19642,445Apr 04 04:23 PM
Vitale LucasCP&BOOMar 18 '25Sale16.604,28771,164135,317Mar 20 04:21 PM
Gillespie Geoffrey CCAOMar 18 '25Sale16.602964,91442,521Mar 20 04:20 PM
Calafiore MassimoPresident & CEOMar 05 '25Buy17.439,914172,801222,404Mar 06 04:27 PM
Last Close
Feb 10  •  10:44AM ET
8.45
Dollar change
+0.19
Percentage change
2.30
%
RXST RxSight Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.88 Insider Own6.14% Shs Outstand41.08M Perf Week1.32%
Market Cap347.43M Forward P/E- EPS next Y-1.11 Insider Trans0.00% Shs Float38.59M Perf Month-4.41%
Enterprise Value131.47M PEG- EPS next Q-0.33 Inst Own81.43% Short Float12.40% Perf Quarter-9.82%
Income-35.73M P/S2.45 EPS this Y-50.09% Inst Trans-12.37% Short Ratio4.95 Perf Half Y27.07%
Sales142.09M P/B1.26 EPS next Y-4.03% ROA-11.54% Short Interest4.78M Perf YTD-18.91%
Book/sh6.72 P/C1.53 EPS next 5Y-14.11% ROE-12.92% 52W High33.08 -74.46% Perf Year-74.42%
Cash/sh5.53 P/FCF- EPS past 3/5Y26.50% - ROIC-12.48% 52W Low6.32 33.70% Perf 3Y-39.25%
Dividend Est.- EV/EBITDA- Sales past 3/5Y83.64% 128.61% Gross Margin74.98% Volatility7.06% 6.72% Perf 5Y-
Dividend TTM- EV/Sales0.93 EPS Y/Y TTM-7.15% Oper. Margin-32.01% ATR (14)0.58 Perf 10Y-
Dividend Ex-Date- Quick Ratio11.44 Sales Y/Y TTM10.75% Profit Margin-25.15% RSI (14)38.69 Recom3.09
Dividend Gr. 3/5Y- - Current Ratio12.74 EPS Q/Q-50.41% SMA20-7.08% Beta1.13 Target Price10.39
Payout- Debt/Eq0.04 Sales Q/Q-14.09% SMA50-19.64% Rel Volume0.56 Prev Close8.26
Employees498 LT Debt/Eq0.04 EarningsNov 05 AMC SMA200-19.98% Avg Volume965.74K Price8.45
IPOJul 30, 2021 Option/ShortYes / Yes EPS/Sales Surpr.36.12% 19.87% Trades Volume124,780 Change2.30%
Date Action Analyst Rating Change Price Target Change
Jan-30-26Initiated William Blair Mkt Perform
Jul-15-25Downgrade Morgan Stanley Overweight → Equal-Weight $9
Jul-10-25Downgrade Jefferies Buy → Hold $9
Jul-09-25Downgrade Wells Fargo Overweight → Equal Weight $9
Jul-09-25Downgrade Oppenheimer Outperform → Perform
Jul-09-25Downgrade BTIG Research Buy → Neutral
May-19-25Upgrade Wells Fargo Equal Weight → Overweight $25
Apr-15-25Initiated Piper Sandler Neutral $18
Apr-09-25Downgrade UBS Buy → Neutral $16
Apr-04-25Downgrade JP Morgan Overweight → Underweight $40 → $17
Jan-30-26 09:54AM
Jan-13-26 06:16AM
Jan-11-26 09:30AM
Jan-02-26 04:05PM
Dec-23-25 12:42PM
05:15PM Loading…
Dec-22-25 05:15PM
Nov-20-25 04:05PM
Nov-06-25 12:04AM
Nov-05-25 06:50PM
04:05PM
Nov-04-25 08:31AM
Oct-22-25 04:05PM
Oct-16-25 04:05PM
Sep-16-25 08:45AM
Sep-15-25 09:32AM
09:00AM Loading…
Sep-09-25 09:00AM
Sep-05-25 04:09PM
Sep-04-25 03:59PM
Aug-25-25 04:05PM
Aug-22-25 08:45AM
Aug-14-25 04:05PM
Aug-13-25 05:14PM
Aug-12-25 09:00AM
Aug-07-25 06:15PM
04:05PM
Aug-04-25 08:05AM
Aug-01-25 09:00AM
Jul-31-25 04:15PM
Jul-30-25 04:02PM
Jul-25-25 04:54PM
04:05PM Loading…
Jul-24-25 04:05PM
Jul-09-25 03:00AM
Jul-08-25 04:05PM
Jul-04-25 11:40AM
Jun-18-25 11:40AM
11:40AM
May-31-25 05:59AM
May-23-25 08:32AM
May-20-25 04:10PM
10:55AM
May-08-25 03:31AM
May-07-25 11:04PM
07:55PM
04:05PM
May-01-25 10:01AM
Apr-30-25 04:05PM
10:01AM
Apr-23-25 04:05PM
Apr-04-25 11:46AM
09:40AM
03:00AM
Apr-03-25 10:39PM
05:57PM
03:54PM
12:59PM
07:32AM
Apr-02-25 08:00PM
Mar-28-25 03:59PM
Mar-25-25 04:05PM
Feb-26-25 02:15AM
Feb-25-25 05:55PM
04:05PM
01:36AM
Feb-11-25 04:10PM
Jan-18-25 07:55AM
Jan-12-25 09:30AM
Jan-02-25 04:05PM
Dec-20-24 09:43AM
Nov-20-24 12:00PM
Nov-08-24 12:02PM
Nov-07-24 07:00PM
04:05PM
Nov-06-24 07:16AM
Oct-24-24 04:05PM
Oct-15-24 06:10PM
Oct-13-24 05:33PM
Aug-22-24 04:05PM
Aug-19-24 03:43PM
Aug-12-24 09:55AM
Aug-06-24 09:55AM
Aug-05-24 06:10PM
04:05PM
11:20AM
Jul-29-24 09:35AM
Jul-22-24 04:05PM
Jul-12-24 09:35AM
Jul-10-24 10:59AM
Jun-18-24 01:50AM
Jun-13-24 11:22AM
Jun-07-24 02:40PM
Jun-05-24 04:05PM
May-30-24 04:00AM
May-28-24 12:00PM
May-24-24 11:40AM
May-13-24 04:58PM
04:05PM
May-08-24 09:15PM
04:05PM
May-07-24 12:17PM
08:50AM
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldshleger IlyaSee remarksSep 25 '25Option Exercise4.2723,44599,99865,691Sep 26 04:07 PM
Weinberg EricSee remarksJun 02 '25Option Exercise3.93188,002738,848195,351Jun 03 06:18 PM
Thunen Shelley BSee remarksApr 14 '25Option Exercise4.347,79233,80638,354Apr 15 08:57 PM
Fountain TamaraDirectorMar 12 '25Sale25.717,000180,00224,793Mar 13 04:46 PM
TAMARA R FOUNTAINDirectorMar 12 '25Proposed Sale25.717,000180,002Mar 12 04:02 PM